BILL ANALYSIS                                                                                                                                                                                                    

                                                                  AB 1709
                                                                  Page  1

          AB 1709 (Conway)
          As Amended  August 20, 2010
          Majority vote
          |ASSEMBLY:  |72-0 |(May 20, 2010)  |SENATE: |32-0 |(August 20,    |
          |           |     |                |        |     |2010)          |
           Original Committee Reference:    AGRI.  

           SUMMARY  :  Deletes and recasts the existing state biologics  
          licensure law to cover animal blood and blood components and  
          products; makes biologics production and biologics products  
          subject to federal authority and permitting, in lieu of the  
          state; and, requires the California Department of Food and  
          Agriculture (CDFA) to assist producers of California biological  
          products to become registered and licensed with the United  
          States Department of Agriculture (USDA), Center for Veterinary  

           The Senate amendments  change and further detail responsibility  
          of CDFA to ensure California biological products become  
          registered and licensed with USDA, Center for Veterinary  

           AS PASSED BY THE ASSEMBLY  , this bill was substantially similar  
          to the version approved by the Senate.

           FISCAL EFFECT  :  According the Senate Committee on  
          Appropriations, avoidance for CDFA of approximately $450,000 per  
          year, by eliminating this program.  

           COMMENTS  :  CDFA has sponsored AB 1709, which proposes to  
          eliminate the state's biologics program for the use and  
          production of animal disease prevention and treatment products  
          within California.  This program was created in 1974 and modeled  
          after USDA's Center for Veterinary Biologics program.  A recent  
          USDA audit of CDFA's current program found that funding  
          shortfalls have jeopardized CDFA's ability to perform the needed  
          specialized training, laboratory testing, and regulatory  
          enforcement activities, to ensure the consumers that these  
          products meet the requirements of being pure, safe, potent and  


                                                                  AB 1709
                                                                  Page  2

          CDFA claims that USDA has agreed to provide a transition period  
          to all companies and assist with the transition of those  
          products currently registered with CDFA over to USDA, and these  
          products will remain available during the transition, according  
          to CDFA.  Affected livestock producers have limited faith in  
          USDA's acceptance of California specific biological products,  
          since they are used in very limited qualities and areas.  To  
          address these concerns, language was added in the Senate to  
          require CDFA to work with producers of California biological  
          products to help them register and become licensed under USDA's  

           Analysis Prepared by  :    Jim Collin / AGRI. / (916) 319-2084 

                                                                FN: 0006175